Jeryl L. Hilleman, Director at NovoCure Ltd (NVCR), sold 2,500 shares at $166.40 ($416K) on 2020-12-18, disclosed to the SEC on 2020-12-22.
Open-market sale of $416k NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SIBN | SELL | 2023-06-20 | $178K | — | Filing → |
| NVCR | SELL | 2022-06-16 | $28K | — | Filing → |
| SIBN | SELL | 2022-06-14 | $27K | — | Filing → |